Peer PrEP Referral + HIV Self-test Delivery for PrEP Initiation in Kenya
PeerPrEP
2 other identifiers
interventional
211
1 country
1
Brief Summary
Few young women at risk of HIV infection are initiating pre-exposure prophylaxis (PrEP) for HIV prevention in Kenya, thus we propose refining and testing a new model to increase PrEP initiation among young women at high HIV risk that has never been explored: enhanced peer PrEP referral with HIV self-test (HIVST) delivery. We conducted formative research to design of a model that is acceptable to young women and feasible to implement in Kenya. In this study, we will refine this model where young (≥16 to 24 years) female PrEP users refer their peers to PrEP and deliver HIVSTs in a pilot study and then test the refined model in a hybrid effectiveness-implementation trial. We hypothesize that relative to standard informal word-of-month peer PrEP referral (currently ongoing in Kenya), enhanced peer PrEP referral with HIVST delivery will increase PrEP initiation, continuation, and adherence among peers; have high fidelity; and be low cost.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 23, 2021
CompletedFirst Posted
Study publicly available on registry
July 29, 2021
CompletedStudy Start
First participant enrolled
February 24, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 5, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 27, 2024
CompletedResults Posted
Study results publicly available
August 7, 2025
CompletedNovember 3, 2025
October 1, 2025
2.3 years
July 23, 2021
June 4, 2025
October 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
cRCT: PrEP Initiation
Number of referred peers that initiated PrEP, among all referred peers, as reported by index peers.
3 months
Pilot: PrEP Initiation, as Reported by Index Peers
Number of referred peers that initiated PrEP, among all eligible referred peers, as reported by index peers.
1 month
Pilot: PrEP Initiation, as Reported by Referred Peers
Number of referred peers that initiated PrEP, among eligible referred peers who enrolled and completed follow-up, as reported by referred peers.
1 month
Secondary Outcomes (6)
Pilot: PrEP Referral
1 month
Pilot: HIVST Use
1 month
cRCT: Recent HIV Testing
3 months
cRCT: PrEP Continuation (Referred Peers)
3 months
cRCT: PrEP Continuation (Index Peers)
3 months
- +1 more secondary outcomes
Other Outcomes (7)
cRCT: PrEP Referral
3 months
cRCT: HIVST Use
3 months
cRCT: Linkage to Care
3 months
- +4 more other outcomes
Study Arms (2)
"Enhanced peer PrEP referral + HIVST delivery"
EXPERIMENTALAfter a brief training, young female PrEP users will be encouraged to refer up to 4 peers to PrEP using strategies gained from the training, PrEP educational materials (i.e., brochures), HIVST kits (2 kits/peer = 8 kits total), and Kenya MOH-style referral cards.
"Standard peer PrEP referral"
NO INTERVENTIONYoung female PrEP users will be encouraged to refer 4 peers to PrEP using informal word-of-mouth recruitment strategies and Kenya MOH-style referral cards.
Interventions
After a brief training, young female PrEP users will be encouraged to refer up to 4 peers to PrEP using strategies gained from the training, PrEP educational materials (i.e., brochures), HIVST kits (2 kits/peer = 8 kits total), and Kenya MOH-style referral cards.
Eligibility Criteria
You may qualify if:
- For peer providers (qualitative data, pilot):
- Age ≥16 to 24 years\*
- Female
- Have been on PrEP for a minimum of three months
- Good adherence to PrEP (i.e., self-report take PrEP all the time)
- Willing to disclose PrEP use to their peers
- Able to identify up to 4 peers at risk of HIV infection
- Willing to participate in training with study counselors on PrEP referral and HIVST use
- Willing to refer peers to PrEP and deliver HIVSTs
- Able and willing to provide written informed consent
- Per the discretion of the site investigator, no clear risks of social harm or inability otherwise to reasonably conduct HIVST at home in the context of PrEP delivery
- For peer providers (cRCT):
- Age ≥16 to 24 years\*
- Female
- Must have refilled or initiated PrEP (i.e., been dispensed PrEP)
- +14 more criteria
You may not qualify if:
- For peer providers (qualitative data, pilot):
- Age ≥16 or \>24 years
- Male
- Have not used PrEP for a minimum of three months
- Not willing to disclose PrEP use to their peers
- Not able to identify up to 4 peers at risk of HIV infection
- Not willing to participate in training with study counselors on PrEP referral and HIVST use
- Not willing to refer peers to PrEP and deliver HIVSTs
- Not able and willing to provide written informed consent
- For peer providers (cRCT):
- Age ≥16 or \>24 years
- Male
- Have not used PrEP
- Currently enrolled in an HIV study
- Not able to identify up to 4 peers at risk of HIV infection
- +9 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Partners in Health and Research Development
Thika, Kenya
Related Publications (2)
Wilson IB, Lee Y, Michaud J, Fowler FJ Jr, Rogers WH. Validation of a New Three-Item Self-Report Measure for Medication Adherence. AIDS Behav. 2016 Nov;20(11):2700-2708. doi: 10.1007/s10461-016-1406-x.
PMID: 27098408BACKGROUNDWairimu N, Malen RC, Reedy AM, Mogere P, Njeru I, Culquichicon C, McGowan M, Gao F, Baeten JM, Ngure K, Ortblad KF. Peer PrEP referral + HIV self-test delivery for PrEP initiation among young Kenyan women: study protocol for a hybrid cluster-randomized controlled trial. Trials. 2023 Nov 4;24(1):705. doi: 10.1186/s13063-023-07734-x.
PMID: 37925450DERIVED
Limitations and Caveats
Limitations included relying on index peers to report outcomes for referred peers in our primary analysis; low enrollment and follow-up among referred peers; relying on self-report for HIV testing and PrEP outcomes; and the relatively short follow-up period for all study participants (one month for pilot and three months for cRCT).
Results Point of Contact
- Title
- Katrina F Ortblad, ScD, MPH
- Organization
- Fred Hutchinson Cancer Center
Study Officials
- PRINCIPAL INVESTIGATOR
Katrina F Ortblad, ScD, MPH
Fred Hutchinson Cancer Center
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 23, 2021
First Posted
July 29, 2021
Study Start
February 24, 2022
Primary Completion
June 5, 2024
Study Completion
August 27, 2024
Last Updated
November 3, 2025
Results First Posted
August 7, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- September 2025 (around the time of publication). No end date.
- Access Criteria
- Anyone who wishes to access the data.
All data (deidentified) used for primary, secondary, and other outcomes reported in the main manuscript along with a data dictionary.